Literature DB >> 6848335

Diffuse panbronchiolitis. A disease of the transitional zone of the lung.

H Homma, A Yamanaka, S Tanimoto, M Tamura, Y Chijimatsu, S Kira, T Izumi.   

Abstract

Diffuse panbronchiolitis (DPB) is a disease with chronic inflammation exclusively located in the region of respiratory bronchioles. The pathologic features of the disease are characterized by thickening of the wall of the respiratory bronchiole with infiltration of lymphocytes, plasma cells and histiocytes, and extension of the inflammatory changes toward peribronchiolar tissues. In the advanced stage, secondary ectasia of proximal bronchioli may occur. These changes appear as diffusely disseminated small nodular shadows throughout both lungs on the chest roentgenogram. Obstructive respiratory functional impairment, occasional symptoms of wheezing, and also cough and sputum resemble the feature of emphysema, bronchial asthma, or chronic bronchitis, respectively. In the advanced stage, large amounts of purulent sputum and dilatation of proximal terminal conducting bronchioli resemble bronchiectasis. However, diffuse panbronchiolitis belongs to a distinctly different category from these diseases, and should be distinguished from them, because it may often show rapid progression with fatal outcome. The disease is dominant in males and the onset is unrelated to age. More than 1,000 cases of probable diffuse panbronchiolitis and 82 histologically-confirmed cases have been collected in Japan.

Entities:  

Mesh:

Year:  1983        PMID: 6848335     DOI: 10.1378/chest.83.1.63

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  53 in total

1.  Detection and characterization of a macrolide 2'-phosphotransferase from a Pseudomonas aeruginosa clinical isolate.

Authors:  A Nakamura; I Miyakozawa; K Nakazawa; K O-Hara; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

2.  Chronic transmural bronchiolitis: a non-specific lesion of small airways.

Authors:  C Edwards; R Cayton; R Bryan
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

3.  Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice.

Authors:  Y Hirakata; M Kaku; K Tomono; K Tateda; N Furuya; T Matsumoto; R Araki; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

4.  Molecular cloning of two novel mucin-like genes in the disease-susceptibility locus for diffuse panbronchiolitis.

Authors:  Minako Hijikata; Ikumi Matsushita; Goh Tanaka; Tomoko Tsuchiya; Hideyuki Ito; Katsushi Tokunaga; Jun Ohashi; Sakae Homma; Yoichiro Kobashi; Yoshio Taguchi; Arata Azuma; Shoji Kudoh; Naoto Keicho
Journal:  Hum Genet       Date:  2010-10-28       Impact factor: 4.132

5.  Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa.

Authors:  A Rutman; R Dowling; P Wills; C Feldman; P J Cole; R Wilson
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

6.  Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin.

Authors:  K Tateda; Y Ishii; T Matsumoto; N Furuya; M Nagashima; T Matsunaga; A Ohno; S Miyazaki; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

7.  Diffuse panbronchiolitis in an Asian immigrant.

Authors:  O Brugiere; B Milleron; M Antoine; M F Carette; C Philippe; C Mayaud
Journal:  Thorax       Date:  1996-10       Impact factor: 9.139

8.  Defective expression of HLA class I antigens: a case of the bare lymphocyte without immunodeficiency.

Authors:  H Maeda; R Hirata; R F Chen; H Suzaki; S Kudoh; H Tohyama
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

9.  Production of leukocidin by clinical isolates of Pseudomonas aeruginosa and antileukocidin antibody from sera of patients with diffuse panbronchiolitis.

Authors:  J Y Homma; M Matsuura; M Shibata; Y Kazuyama; M Yamamoto; Y Kubota; T Hirayama; I Kato
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

10.  Effects of sub-MICs of erythromycin and other macrolide antibiotics on serum sensitivity of Pseudomonas aeruginosa.

Authors:  K Tateda; Y Hirakata; N Furuya; A Ohno; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.